| Viyash Scientific Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 512529 |
NSE Symbol : VIYASH |
P/E(TTM) : 112.13 |
|
ISIN Demat : INE807F01027 |
Div & Yield% : 0.00 |
EPS(TTM) : 2.40 |
|
Book Value(₹) : 73.00 |
Market Cap(₹Cr) : 11,756.32 |
Face Value(₹) : 2.00 |
| Particulars | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 372.49 | 341.64 | 339.75 | 41.07 | 42.33 | 338.05 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 372.49 | 341.64 | 339.75 | 41.07 | 42.33 | 338.05 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 19.75 | 16.29 | 17.32 | 11.48 | 12.27 | 15.97 |
| Total Income | 392.24 | 357.93 | 357.07 | 52.55 | 54.60 | 354.02 |
| Total Expenditure | 309.80 | 312.56 | 289.40 | 44.36 | 45.40 | 282.66 |
| PBIDT | 82.44 | 45.37 | 67.67 | 8.19 | 9.20 | 71.36 |
| Interest | 2.53 | 3.56 | 4.10 | 1.08 | 0.99 | 5.91 |
| PBDT | 79.91 | 41.81 | 63.57 | 7.11 | 8.21 | 65.45 |
| Depreciation | 31.16 | 31.20 | 30.90 | 2.33 | 2.30 | 31.81 |
| Tax | 14.98 | -25.69 | 14.71 | 0.84 | 1.11 | 12.40 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -2.04 | 36.38 | -4.88 | 0.57 | 0.57 | -29.89 |
| Reported Profit After Tax | 35.81 | -0.08 | 22.84 | 3.37 | 4.23 | 51.13 |
| Extra-ordinary Items | 0.00 | -4.88 | -0.93 | -0.88 | -0.18 | -1.82 |
| Adjusted Profit After Extra-ordinary item | 35.81 | 4.80 | 23.77 | 4.25 | 4.41 | 52.95 |
| EPS (Unit Curr.) | 0.82 | 0.00 | 0.53 | 0.14 | 0.17 | 1.20 |
| EPS (Adj) (Unit Curr.) | 0.82 | 0.00 | 0.53 | 0.14 | 0.17 | 1.20 |
| Calculated EPS (Unit Curr.) | 0.82 | 0.00 | 0.91 | 0.13 | 0.17 | 2.04 |
| Calculated EPS (Adj) (Unit Curr.) | 0.82 | 0.00 | 0.91 | 0.13 | 0.17 | 2.04 |
| Calculated EPS (Ann.) (Unit Curr.) | 3.28 | -0.01 | 3.63 | 0.54 | 0.68 | 8.17 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 3.28 | -0.01 | 3.63 | 0.54 | 0.68 | 8.17 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 87.37 | 87.22 | 50.33 | 50.07 | 50.06 | 50.05 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 22.13 | 13.28 | 19.92 | 19.94 | 21.73 | 21.11 |
| PBDTM(%) | 21.45 | 12.24 | 18.71 | 17.31 | 19.40 | 19.36 |
| PATM(%) | 9.61 | -0.02 | 6.72 | 8.21 | 9.99 | 15.12 |
